FDA Inspection 779822 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on March 20, 2012 in Bagsvard. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bagsvard (Denmark)